The US Food and Drug Administration is collaborating with the National Institute of Standards and Technology (NIST) as part of a push to upgrade US medtech manufacturing capabilities, outgoing FDA commissioner Stephen Hahn announced in a 15 January blog post.
FDA, NIST Join Forces To Improve Manufacturing, Quell Device Shortages
The focus on innovative manufacturing will also include a new clearinghouse to share info about advanced manufacturing technology within the US agency’s device center.
More from Regulation
• By
Ireland’s NSAI reinstated under IVD Regulation designation list
• By
The preliminary White House 2026 budget plan cuts agency funding, but not so sharply that user fees are excluded from collection.
• By
Abbott and J&J reassured investors they will maintain their 2025 profit forecasts. Abbott projects $5.05 to $5.25 per share and plans a new $500m investment in manufacturing and R&D sites. J&J anticipates $400m in tariff-related costs but committed $55bn in US investment over four years.
• By
Will challenges in the way of designations of notified bodies that assess AI-enabled medical devices create delays and bottlenecks and slow EU medtech innovation?